International Journal of
Reproductive Biomedicine
Tue, Apr 23, 2024
[Archive]
Volume 20, Issue 6 (June 2022)
IJRM 2022, 20(6): 477-482 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Barati M, Nasehi N, Aberoumand S, Najafian M, Emami Moghadam A. Factors causing timely referral for fetal echocardiography in the final diagnosis of congenital heart malformations: A cross-sectional study. IJRM 2022; 20 (6) :477-482
URL: http://ijrm.ir/article-1-1975-en.html
URL: http://ijrm.ir/article-1-1975-en.html
Mojgan Barati1 
, Nahal Nasehi1 , Sareh Aberoumand * 2, Mahin Najafian1 , Abdolrahman Emami Moghadam3
, Nahal Nasehi1 , Sareh Aberoumand * 2, Mahin Najafian1 , Abdolrahman Emami Moghadam3
1- Fertility, Infertility, and Perinatology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
2- Fertility, Infertility, and Perinatology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. , saraaberumand@yahoo.com
3- Department of Pediatric Cardiology, Golestan Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
2- Fertility, Infertility, and Perinatology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. , saraaberumand@yahoo.com
3- Department of Pediatric Cardiology, Golestan Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Full-Text [PDF 264 kb]
(663 Downloads)
| Abstract (HTML) (844 Views)
1. Introduction
Congenital heart disease (CHD) is one of the most common cardiac complications during pregnancy and a frequent type of birth defect that is associated with adverse outcomes. This flaw is a type of prenatal cardiovascular illness that includes structural disorders in the heart or large veins. The prevalence of this malformation is about 8 individuals per 1000 living childbirths. Besides, the prevalence of this congenital defect in aborted fetuses, stillbirths and premature infants has been reported as 10-25%, 3-4% and 2%, respectively (1, 2). The prevalence of CHD is 6 and 4 times higher than chromosomal abnormalities and neural tube defects, respectively (3). About 20-30% of cases of CHD are life-threatening and require surgery in the first year of life (4, 5). More than 50% of child mortality attributable to birth defects is related to CHD (6, 7).
Fetal echocardiography is an imaging procedure that provides quality images and detailed anatomy, and is used for the diagnosis of fetal cardiac anomalies (8). The development of fetal echocardiography has made the diagnosis of CHD possible, and evidence suggests that prenatal diagnosis has significantly altered the management of the disease (9, 10). Early detection of heart disorders has many advantages. Prenatal screening and diagnosis increase survival rates and reduce complications (11, 12). Prenatal diagnosis not only identifies heart disorders, but also detects the associated abnormalities; it provides an accurate view of the condition and, if necessary, the possibility of termination of pregnancy (12, 13). However, despite these advances, most prenatal CHD cases remain unidentified, and this is why continuous innovation and advances in technology and training are needed (14, 15).
This study aimed to determine the referral cause for fetal echocardiography in the final diagnosis of major CHD.
2. Materials and Methods
2.1. Study setting and participants
The medical records of all pregnant women referred to Narges Clinic, Ahvaz, Iran from January 2017 to January 2020, for fetal echocardiography with any reason (including the history of abortion, ultrasound problems, gestational diabetes, chronic diabetes, history of stillbirth, high body mass, etc.) were reviewed. All files with incomplete information were excluded.
2.2. Variables and measurement
The data included abnormality in ultrasounds, history of abortion, increased nuchal translucency (NT), gestational diabetes, having a previous child with Down syndrome, having a previous child with heart disease, history of stillbirth, hypothyroidism, taking medicine during pregnancy, no underlying disease, multiple pregnancies, high-risk screening, in vitro fertilization (IVF) pregnancy, and having a previous child with an intellectual disability.
2.3. Ethical considerations
This study was approved by the Ethics Committee of Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran (Code: IR.AJUMS.REC.1399.392). This study was conducted in accordance with the Helsinki Declaration of 1975, as revised in 2013. The principle of confidentiality of information was fully observed.
2.4. Statistical analysis
In this study, to analyze the information and obtained data the descriptive statistics (frequency and percentage) have been used in the form of SPSS software version 21.0 (Statistical Package for the Social Sciences, SPSS Inc, Chicago, Illinois, USA).
3. Results
Out of 1772 cases reviewed, only 33 women (1.8%) had a fetus diagnosed with major CHD on echocardiography. The mean ± SD of pregnant women's age and gestational age were 31.7 ± 3.1 yr, 21.4 ± 4.3 wk, respectively. Almost half of the pregnant women with abnormal echocardiography had a normal body mass index (45.5%). Nearly half of all pregnant women were nullipara (48.5%), and more than a third had a history of one-time deliveries (36.4%) (Table I). The main reasons for referring these women for echocardiography were abnormality in ultrasounds (n = 19, 57.6%), and history of abortion (n = 12; 36.5%), while IVF pregnancies (n = 1; 3.0%), high-risk screening (n = 1; 3.0%) and having a child with intellectual disability (n = 1; 3.0%) were less frequent cases (Table II).
An important aspect of this study which needs to be highlighted is the gestational age at which the mothers were referred for fetal echocardiography. The mean gestational age at referral in those suspected CHD in ultrasonography was 21.4 ± 4.3 wk. It may be late for any decision. The researchers stated 11-13 wk and on average 20.37 in their surveys, respectively (16, 18). According to the studies, the most detected cardiac abnormalities were diagnosed at 16-19 wk of gestation (19).
Thus, the timing of referral in our study seems to be postponed. Detection of a defect or CHD is very important in the early stages of disease progression because in such cases the treatment methods efficiently work (20).
In a study, it was recommended that women with pre-pregnancy diabetes should have an echocardiogram before 20th wk for CHD, and that in diabetic women (pregnancy and pre-pregnancy) with low diabetes control, a fetal echocardiogram should be recommended in the third trimester (21). In our study 18.2% of pregnant women had gestational diabetes mellitus.
As mentioned in this study, it was found that the most common indication for referral for fetal echocardiography in pregnant women referred to the echocardiography department, CHD in ultrasound (57.6%) and the lowest frequency were related to having high-risk screening, IVF pregnancy and having a previous child with intellectual disability, the frequency of each of which was 1%. The finding of another study confirms our results (21). Also, in another study, the most common primary indication for referral was abnormal cardiac findings on prenatal ultrasound examinations, which were observed in 54 cases (23.3%) of 276 cases (22).
The next commonest indication for referral in this study was history of abortion (36.5%). Only 18.2% of pregnant women were referred for fetal echocardiography due to increased NT. This may be either because the number of fetuses with increased NT is very less or there is lack of awareness about the important correlation between increased NT and CHD. NT increases with crown rump length (CRL) and hence is usually measured in percentiles in relation to CRL. The 95th centile of NT for a CRL of 38 is 2.2 mm and for a CRL of 84 is 2.8 mm, whereas the 99th centile (3.5 mm) does not change significantly with CRL (23).
Increased NT has been well known to be associated with higher incidence of CHD, and this incidence increases with higher values of NT. The CHD prevalence was 0.8/1000 pregnancy when the NT was below 95th centile, while it increased to 63.5 per 1000 when NT was above 99th centile (23). Due to the proven correlation between NT and CHD, we would like to impress the need for a uniform pattern of NT measurement and referral for a detailed fetal echo if NT value is greater than at least 99th centile. Such fetuses should be referred for early fetal echo rather than waiting till 18-20 wk.
Diagnosis of CHD has significant implications for overall fetal health; so where heart ill health is suspected, such as in cases of chromosomal or fetal diseases, fetal non-cardiac abnormalities shown in an ultrasound, fetal heart irregularities, placental coronary placenta, increased NT thickness on an ultrasound, or suspected cardiac abnormalities, it is recommended that a conventional ultrasound and fetal echocardiography are performed, especially as fetal echocardiography does not harm the fetus or the mother (24).
If a fetal echocardiogram shows a problem, since most CHD is treatable, it is necessary to plan for delivery in a hospital that has the necessary facilities for the care of such babies. With the advancement of science, most of the heart diseases observed in the fetus can be prevented or treated, and there is no need to worry (25).
The best time to do fetal echocardiography is before the end of the 18th wk of pregnancy, because until then if diagnosed with incurable heart disease, it is possible to terminate the pregnancy, but after that, termination of the pregnancy will be unauthorized (26). Therefore, it is recommended that women get genetic counseling before they become pregnant if they are aware of a specific disease in their family. Proper genetic counseling can prevent the birth defect so that the life of the mother and child will not be affected by a congenital disease (27).
Finally, it is possible for some women to have problems with their fetal heart during pregnancy, some of which include mothers who had a child with a heart problem during a previous pregnancy, those who have a history of CHD, women taking some of drugs (such as medications for blood pressure, diabetes, or lupus), women who became pregnant with assisted reproductive techniques such as IVF, or women with a twin pregnancy. If any problems are seen during the first and second trimesters, a fetal heart echocardiogram should be done to make sure the fetus is healthy.
5. Conclusion
Abnormality in ultrasounds, a history of abortion, and increased NT were identified as the most common reasons for referral fetal echocardiography. Fetal echocardiography is a non-invasive method for early detection of CHD, which is suitable not only for high-risk pregnancies but also for low-risk pregnancies. Given that in some cases, despite a normal pregnancy ultrasound and lack of indications for echocardiography during pregnancy, we see congenital heart defects after birth, we recommend that fetal echocardiography be routinely performed for all pregnant women.
Acknowledgments
This study was funded by Ahvaz Jundishapur University of Medical Sciences (AJUMS), Ahvaz, Iran (Ethics Code: IR.AJUMS.REC.1399.392). The authors also would like to express their special gratitude to the Narges diagnostic clinic staff, Ahvaz, Iran, and to the people who enrolled in the study.
Full-Text: (231 Views)
1. Introduction
Congenital heart disease (CHD) is one of the most common cardiac complications during pregnancy and a frequent type of birth defect that is associated with adverse outcomes. This flaw is a type of prenatal cardiovascular illness that includes structural disorders in the heart or large veins. The prevalence of this malformation is about 8 individuals per 1000 living childbirths. Besides, the prevalence of this congenital defect in aborted fetuses, stillbirths and premature infants has been reported as 10-25%, 3-4% and 2%, respectively (1, 2). The prevalence of CHD is 6 and 4 times higher than chromosomal abnormalities and neural tube defects, respectively (3). About 20-30% of cases of CHD are life-threatening and require surgery in the first year of life (4, 5). More than 50% of child mortality attributable to birth defects is related to CHD (6, 7).
Fetal echocardiography is an imaging procedure that provides quality images and detailed anatomy, and is used for the diagnosis of fetal cardiac anomalies (8). The development of fetal echocardiography has made the diagnosis of CHD possible, and evidence suggests that prenatal diagnosis has significantly altered the management of the disease (9, 10). Early detection of heart disorders has many advantages. Prenatal screening and diagnosis increase survival rates and reduce complications (11, 12). Prenatal diagnosis not only identifies heart disorders, but also detects the associated abnormalities; it provides an accurate view of the condition and, if necessary, the possibility of termination of pregnancy (12, 13). However, despite these advances, most prenatal CHD cases remain unidentified, and this is why continuous innovation and advances in technology and training are needed (14, 15).
This study aimed to determine the referral cause for fetal echocardiography in the final diagnosis of major CHD.
2. Materials and Methods
2.1. Study setting and participants
The medical records of all pregnant women referred to Narges Clinic, Ahvaz, Iran from January 2017 to January 2020, for fetal echocardiography with any reason (including the history of abortion, ultrasound problems, gestational diabetes, chronic diabetes, history of stillbirth, high body mass, etc.) were reviewed. All files with incomplete information were excluded.
2.2. Variables and measurement
The data included abnormality in ultrasounds, history of abortion, increased nuchal translucency (NT), gestational diabetes, having a previous child with Down syndrome, having a previous child with heart disease, history of stillbirth, hypothyroidism, taking medicine during pregnancy, no underlying disease, multiple pregnancies, high-risk screening, in vitro fertilization (IVF) pregnancy, and having a previous child with an intellectual disability.
2.3. Ethical considerations
This study was approved by the Ethics Committee of Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran (Code: IR.AJUMS.REC.1399.392). This study was conducted in accordance with the Helsinki Declaration of 1975, as revised in 2013. The principle of confidentiality of information was fully observed.
2.4. Statistical analysis
In this study, to analyze the information and obtained data the descriptive statistics (frequency and percentage) have been used in the form of SPSS software version 21.0 (Statistical Package for the Social Sciences, SPSS Inc, Chicago, Illinois, USA).
3. Results
Out of 1772 cases reviewed, only 33 women (1.8%) had a fetus diagnosed with major CHD on echocardiography. The mean ± SD of pregnant women's age and gestational age were 31.7 ± 3.1 yr, 21.4 ± 4.3 wk, respectively. Almost half of the pregnant women with abnormal echocardiography had a normal body mass index (45.5%). Nearly half of all pregnant women were nullipara (48.5%), and more than a third had a history of one-time deliveries (36.4%) (Table I). The main reasons for referring these women for echocardiography were abnormality in ultrasounds (n = 19, 57.6%), and history of abortion (n = 12; 36.5%), while IVF pregnancies (n = 1; 3.0%), high-risk screening (n = 1; 3.0%) and having a child with intellectual disability (n = 1; 3.0%) were less frequent cases (Table II).
4. Discussion
The aim of this study was to determine the referral indications for fetal echocardiography. In the present study, referred pregnant women were 31.7 ± 3.1 yr-old, similar to other studies (16, 17). But in another study, the mean age of the population was 27.6 ± 4.6, slightly younger in age (18).An important aspect of this study which needs to be highlighted is the gestational age at which the mothers were referred for fetal echocardiography. The mean gestational age at referral in those suspected CHD in ultrasonography was 21.4 ± 4.3 wk. It may be late for any decision. The researchers stated 11-13 wk and on average 20.37 in their surveys, respectively (16, 18). According to the studies, the most detected cardiac abnormalities were diagnosed at 16-19 wk of gestation (19).
Thus, the timing of referral in our study seems to be postponed. Detection of a defect or CHD is very important in the early stages of disease progression because in such cases the treatment methods efficiently work (20).
In a study, it was recommended that women with pre-pregnancy diabetes should have an echocardiogram before 20th wk for CHD, and that in diabetic women (pregnancy and pre-pregnancy) with low diabetes control, a fetal echocardiogram should be recommended in the third trimester (21). In our study 18.2% of pregnant women had gestational diabetes mellitus.
As mentioned in this study, it was found that the most common indication for referral for fetal echocardiography in pregnant women referred to the echocardiography department, CHD in ultrasound (57.6%) and the lowest frequency were related to having high-risk screening, IVF pregnancy and having a previous child with intellectual disability, the frequency of each of which was 1%. The finding of another study confirms our results (21). Also, in another study, the most common primary indication for referral was abnormal cardiac findings on prenatal ultrasound examinations, which were observed in 54 cases (23.3%) of 276 cases (22).
The next commonest indication for referral in this study was history of abortion (36.5%). Only 18.2% of pregnant women were referred for fetal echocardiography due to increased NT. This may be either because the number of fetuses with increased NT is very less or there is lack of awareness about the important correlation between increased NT and CHD. NT increases with crown rump length (CRL) and hence is usually measured in percentiles in relation to CRL. The 95th centile of NT for a CRL of 38 is 2.2 mm and for a CRL of 84 is 2.8 mm, whereas the 99th centile (3.5 mm) does not change significantly with CRL (23).
Increased NT has been well known to be associated with higher incidence of CHD, and this incidence increases with higher values of NT. The CHD prevalence was 0.8/1000 pregnancy when the NT was below 95th centile, while it increased to 63.5 per 1000 when NT was above 99th centile (23). Due to the proven correlation between NT and CHD, we would like to impress the need for a uniform pattern of NT measurement and referral for a detailed fetal echo if NT value is greater than at least 99th centile. Such fetuses should be referred for early fetal echo rather than waiting till 18-20 wk.
Diagnosis of CHD has significant implications for overall fetal health; so where heart ill health is suspected, such as in cases of chromosomal or fetal diseases, fetal non-cardiac abnormalities shown in an ultrasound, fetal heart irregularities, placental coronary placenta, increased NT thickness on an ultrasound, or suspected cardiac abnormalities, it is recommended that a conventional ultrasound and fetal echocardiography are performed, especially as fetal echocardiography does not harm the fetus or the mother (24).
If a fetal echocardiogram shows a problem, since most CHD is treatable, it is necessary to plan for delivery in a hospital that has the necessary facilities for the care of such babies. With the advancement of science, most of the heart diseases observed in the fetus can be prevented or treated, and there is no need to worry (25).
The best time to do fetal echocardiography is before the end of the 18th wk of pregnancy, because until then if diagnosed with incurable heart disease, it is possible to terminate the pregnancy, but after that, termination of the pregnancy will be unauthorized (26). Therefore, it is recommended that women get genetic counseling before they become pregnant if they are aware of a specific disease in their family. Proper genetic counseling can prevent the birth defect so that the life of the mother and child will not be affected by a congenital disease (27).
Finally, it is possible for some women to have problems with their fetal heart during pregnancy, some of which include mothers who had a child with a heart problem during a previous pregnancy, those who have a history of CHD, women taking some of drugs (such as medications for blood pressure, diabetes, or lupus), women who became pregnant with assisted reproductive techniques such as IVF, or women with a twin pregnancy. If any problems are seen during the first and second trimesters, a fetal heart echocardiogram should be done to make sure the fetus is healthy.
5. Conclusion
Abnormality in ultrasounds, a history of abortion, and increased NT were identified as the most common reasons for referral fetal echocardiography. Fetal echocardiography is a non-invasive method for early detection of CHD, which is suitable not only for high-risk pregnancies but also for low-risk pregnancies. Given that in some cases, despite a normal pregnancy ultrasound and lack of indications for echocardiography during pregnancy, we see congenital heart defects after birth, we recommend that fetal echocardiography be routinely performed for all pregnant women.
Acknowledgments
This study was funded by Ahvaz Jundishapur University of Medical Sciences (AJUMS), Ahvaz, Iran (Ethics Code: IR.AJUMS.REC.1399.392). The authors also would like to express their special gratitude to the Narges diagnostic clinic staff, Ahvaz, Iran, and to the people who enrolled in the study.
Type of Study: Original Article |
Subject:
Perinatology
References
1. Suter S, Yagel S, Silverman NH, Gembruch U. Fetal cardiology: Embryology, genetics, physiology, echocardiographic evaluation, diagnosis and perinatal management of cardiac diseases. Eur J Pediatr 2003; 162: 658. [DOI:10.1007/s00431-003-1243-6]
2. Sadowski ShL. Congenital cardiac disease in the newborn infant: Past, present, and future. Crit Care Nurs Clin North Am 2009; 21: 37-48. [DOI:10.1016/j.ccell.2008.10.001] [PMID]
3. Carvalho JS, Mavrides E, Shinebourne EA, Campbell S, Thilaganathan B. Improving the effectiveness of routine prenatal screening for major congenital heart defects. Heart 2002; 88: 387-391. [DOI:10.1136/heart.88.4.387] [PMID] [PMCID]
4. Khalil M, Jux Ch, Rueblinger L, Behrje J, Esmaeili A, Schranz D. Acute therapy of newborns with critical congenital heart disease. Transl Pediatr 2019; 8: 114-126. [DOI:10.21037/tp.2019.04.06] [PMID] [PMCID]
5. Zeng Zh, Zhang H, Liu F, Zhang N. Current diagnosis and treatments for critical congenital heart defects. Exp Ther Med 2016; 11: 1550-1554. [DOI:10.3892/etm.2016.3167] [PMID] [PMCID]
6. Petrini J, Damus K, Russell R, Poschman K, Davidoff MJ, Mattison D. Contribution of birth defects to infant mortality in the United States. Teratology 2002; 66 (Suppl.): S3-S6. [DOI:10.1002/tera.90002] [PMID]
7. Yang Q, Chen H, Correa A, Devine O, Mathews TJ, Honein MA. Racial differences in infant mortality attributable to birth defects in the United States, 1989-2002. Birth Defects Res A Clin Mol Teratol 2006; 76: 706-713. [DOI:10.1002/bdra.20308] [PMID]
8. Lee W, Allan L, Carvalho JS, Chaoui R, Copel J, Devore G, et al. ISUOG consensus statement: What constitutes a fetal echocardiogram? Ultrasound Obstet Gynecol 2008; 32: 239-242. [DOI:10.1002/uog.6115] [PMID]
9. Maulik D, Nanda NC, Maulik D, Vilchez G. A brief history of fetal echocardiography and its impact on the management of congenital heart disease. Echocardiography 2017; 34: 1760-1767. [DOI:10.1111/echo.13713] [PMID]
10. Li Y, Hua Y, Fang J, Wang Ch, Qiao L, Wan Ch, et al. Performance of different scan protocols of fetal echocardiography in the diagnosis of fetal congenital heart disease: A systematic review and meta-analysis. PLoS One 2013; 8: e65484. [DOI:10.1371/journal.pone.0065484] [PMID] [PMCID]
11. von Dadelszen P, Magee LA. Preventing deaths due to the hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 2016; 36: 83-102. [DOI:10.1016/j.bpobgyn.2016.05.005] [PMID] [PMCID]
12. van Velzen CL, Haak MC, Reijnders G, Rijlaarsdam MEB, Bax CJ, Pajkrt E, et al. Prenatal detection of transposition of the great arteries reduces mortality and morbidity. Ultrasound Obstet Gynecol 2015; 45: 320-325. [DOI:10.1002/uog.14689] [PMID]
13. Carlson LM, Vora NL. Prenatal diagnosis: Screening and diagnostic tools. Obstet Gynecol Clin North Am 2017; 44: 245-256. [DOI:10.1016/j.ogc.2017.02.004] [PMID] [PMCID]
14. Kearns AD, Caglia JM, Ten Hoope-Bender P, Langer A. Antenatal and postnatal care: A review of innovative models for improving availability, accessibility, acceptability and quality of services in low-resource settings. BJOG 2016; 123: 540-548. [DOI:10.1111/1471-0528.13818] [PMID]
15. Van den Veyver IB. Recent advances in prenatal genetic screening and testing. F1000Res 2016; 5: 2591. [DOI:10.12688/f1000research.9215.1] [PMID] [PMCID]
16. Wiechec M, Knafel A, Nocun A. Prenatal detection of congenital heart defects at the 11-to 13-week scan using a simple color Doppler protocol including the 4-chamber and 3-vessel and trachea views. J Ultrasound Med 2015; 34: 585-594. [DOI:10.7863/ultra.34.4.585] [PMID]
17. Ghiasi Sh, Mottaghi Moghaddam Shahri H, Heidari E. Fetal echocardiography indications: A single center experience. Int J Pediatr 2019; 7: 8969-8976.
18. Sharma S, Kaur N, Kaur K, Pawar NC. Role of echocardiography in prenatal screening of congenital heart diseases and its correlation with postnatal outcome. J Clin Diagnos Res 2017; 11: TC12. [DOI:10.7860/JCDR/2017/25929.9750] [PMID] [PMCID]
19. Stümpflen I, Stümpflen A, Wimmer M, Bernaschek G. Effect of detailed fetal echocardiography as part of routine prenatal ultrasonographic screening on detection of congenital heart disease. Lancet 1996; 348: 854-857.
https://doi.org/10.1016/S0140-6736(96)04069-X [DOI:10.1016/S0140-6736(05)65853-9]
20. Ferentzi H, Pfitzer C, Rosenthal LM, Berger F, Schmitt KRL. Long-term early development research in congenital heart disease (LEADER-CHD): A study protocol for a prospective cohort observational study investigating the development of children after surgical correction for congenital heart defects during the first 3 years of life. BMJ Open 2017; 7: e018966. [DOI:10.1136/bmjopen-2017-018966] [PMID] [PMCID]
21. Nair A, Radhakrishnan S. Evaluation of referral pattern for fetal echocardiography at a tertiary care center in Northern India and its implications. J Obstet Gynaecol India 2016; 66 (Suppl.): 258-262. [DOI:10.1007/s13224-016-0872-4] [PMID] [PMCID]
22. Simpson LL. Indications for fetal echocardiography from a tertiary-care obstetric sonography practice. J Clin Ultrasound 2004; 32: 123-128. [DOI:10.1002/jcu.20007] [PMID]
23. Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: Population-based cohort study. BMJ 1999; 318: 81-85. [DOI:10.1136/bmj.318.7176.81] [PMID] [PMCID]
24. Kulkarni S. Does fetal echo help the fetus? Ann Pediatr Cardiol 2013; 6: 21-23.
25. Donofrio MT, Moon-Grady AJ, Hornberger LK, Copel JA, Sklansky MS, Abuhamad A, et al. Diagnosis and treatment of fetal cardiac disease: A scientific statement from the American heart association. Circulation 2014; 129: 2183-2242. [DOI:10.1161/01.cir.0000437597.44550.5d] [PMID]
26. Carvalho JS, Moscoso G, Tekay A, Campbell S, Thilaganathan B, Shinebourne EA. Clinical impact of first and early second trimester fetal echocardiography on high-risk pregnancies. Heart 2004; 90: 921-926. [DOI:10.1136/hrt.2003.015065] [PMID] [PMCID]
27. Wieacker P, Steinhard J. The prenatal diagnosis of genetic diseases. Dtsch Arztebl Int 2010; 107: 857-862. [DOI:10.3238/arztebl.2010.0857] [PMID] [PMCID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
